Results

Total Results: 1,528 records

Showing results for "drugs".

221. Medical Care Journal Supplement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
     January 01, 2007 - Assessment of Adherence to and Persistence on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Patients … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic

222. Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-jaw-rapid-response.pdf
     May 01, 2025 - the jaw (MRONJ) before, during, or after treatment with bisphosphonates, antiangiogenics, and other drugs … A growing body of evidence suggests that corticosteroids and anti- angiogenic drugs can exacerbate the … Furthermore, more uses for antiangiogenic drugs are being explored across osteoporosis, such as current … Review and Update on Drugs Related to the Development of Osteonecrosis of the Jaw. … (63) Drugs@FDA: FDA-Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/ daf/index.cfm?

223. Disposition of Comments for CER 159 Insomnia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
     December 30, 2015 - We did not identify eligible trials of antihistaminergic drugs or alcohol. … We have added text describe how specific drugs or formulations can be used to target specific sleep … problems (Introduction: ‘Drugs can be specifically formulated…’). … One of the most commonly used drugs for insomnia. No evidence. … Drugs Aging. 2014 Oct;31(10):731-6. doi: 10.1007/s40266-014-0211-3.

224. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … available in generic form from several manufacturers, as well as in branded form, as Ketalar® (JHP Pharmaceuticals … CNS Drugs. 2012 Mar 1;26(3):189-204. … PMID: 14640353 http://www.cesar.umd.edu/cesar/drugs/ketamine.pdf http://www.cesar.umd.edu/cesar/drugs … Rochester (MI): JHP Pharmaceuticals, LLC; 2011 Jun. 4 p.

225. Insomnia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
     December 01, 2015 - Prescription drugs are often used to treat insomnia. … We found the most data on the newer FDA-approved drugs. … Results for adverse effects varied across the different drugs and typically were not different from … Drug trials for certain drugs often used doses that are no longer recommended by the FDA. … Drug Class Review: Newer Drugs for Insomnia: Final Report Update 2 [Internet].

226. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
     December 29, 2020 - Dosing of nonsteroidal anti-inflammatory drugs (NSAIDS). … No not everyone who is on an opiod ends up on street drugs. … This war on drugs came into existence during the Nixon era. … We still have more people overdosing on drugs and alcohol than ever before. … It is illegal drugs that are causing our problem and lack of education of our citizens.

227. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … below lists the three topics for which (1) preliminary phase III or bioequivalence study data for drugs

228. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Drugs that are not approved by the FDA have been removed. … Drugs that are not approved by the FDA have been removed. … Weiglein; Takeda Pharmaceuticals North America, Inc Results 1. … Weiglein; Takeda Pharmaceuticals North America, Inc Results 1. … Weiglein; Takeda Pharmaceuticals North America, Inc Discussion 1.

229. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
     December 01, 2013 - Telaprevir Telaprevir (Incivek™, Vertex Pharmaceuticals, Inc., Cambridge, MA) is orally administered … Optimer Pharmaceuticals announced a 2-year agreement with Cubist Pharmaceuticals, Inc. … Tibotec Pharmaceuticals, Vertex Pharmaceuticals. … Berlin: Vertex Pharmaceuticals; 2011 Mar 31 [accessed 2011 May 17]. [4 p]. … (FDA briefing document for Anti-Infective Drugs Advisory committee meeting).

230. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists the six topics for which (1) preliminary phase III data for drugs, at … of this therapy for both drugs. … Therapeutics, Inc., Hayward, CA), is extended-release exenatide for injection (Bydureon™, Amylin Pharmaceuticals … Get drugs straight to the eye. [internet].

231. Treatment of Dementia Among Community-Dwelling and Institutionalized Medicare Beneficiaries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
     May 01, 2008 - Use of anti-dementia drugs was similar across settings, with 24.7% of dementia cases in the community … larger than in the community, but there is little difference in the proportions receiving anti-dementia drugs … In a previous study, the authors13 reviewed 81 recent randomized clinical trials of dementia drugs … Our analysis of drugs typically used to treat behavioral manifestations of dementia found that treatment … these utilization rates are not adjusted for potential confounding factors, we cannot conclude the drugs

232. S149 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
     October 01, 2007 - longitudinal pro- pensity score to compare outcomes between a new drug (exenatide) and established drugs … We used our methods to estimate the effect of the new versus established drugs on total health care charges … Additionally, a separate, linkable file is available which includes pharmacy claims for prescription drugs … May 2005 14,052 0.00 0.46 0.45 Emergency room visit June 2005 36 0.00 0.47 0.49 No. drugs June 2005 … This methodology has particular value for the study of new drugs.

233. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Drugs Today 2010;46(1):49-67. 3. Sorbera LA, Dulsat C, Rosa E. … East Hanover (NJ): Novartis Pharmaceuticals Corporation; 2011 Jul. 21 p. … Drugs Future 2010;35(2):93-7. … Drugs Today (Barc) 2010 Nov;46(11):815-22. PMID: 21225020 30. … Mountain View (CA): MAP Pharmaceuticals, Inc.; [accessed 2011 Jan 6]. [1 p].

234. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
     April 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The table below lists the three topics for which (1) preliminary phase III were available for drugs … Impact Interventions Report, we aggregated related topics for summary and discussion (e.g., individual drugs

235. EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
     January 09, 2020 - However, simple analgesics including 2 nonsteroidal anti-inflammatory drugs (NSAIDs) used … reason, the American Headache Society has explicitly stated that opioids and butalbital-containing drugs … therapy versus: 1) nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … effectiveness of nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … , topical nonopioid abortive drug, including: • Acetaminophen • Nonsteroidal anti-inflammatory drugs

236. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
     September 01, 2011 - Currently, nine atypical antipsychotic drugs have been approved by FDA: aripiprazole, asenapine, clozapine … These drugs have been used off-label (i.e., for indications not approved by FDA) for the treatment of … While it is legal for a physician to prescribe drugs in such a manner, it is illegal for the manufacturer … How do they compare within the class and with other drugs used for the conditions? … How do they compare within the class and with other drugs used for the conditions?

237. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Results The table below lists two topics for which (1) preliminary phase III data for drugs or phase … We continue tracking novel drugs and interventions such as fecal microbiota therapy for ulcerative … Raleigh (NC): Salix Pharmaceuticals, Inc.; 2014 Mar. 19 p. 34. Salix Pharmaceuticals, Inc. … Raliegh (NC): Salix Pharmaceuticals, Inc.; 2015 May. 7 p. … Raleigh (NC): Salix Pharmaceuticals; 1 p.

238. Alcohol-Misuse-Drug-Therapy Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
     January 27, 2012 - The following designs were also eligible for KQ 3 if they compared two or more drugs of interest: nonrandomized … cohort studies, and case-control studies were eligible as long as the studies compared two or more drugs … J Stud Alcohol Drugs. 2008 Jul;69(4):535-8. PMID: 18612569. 19. … J Stud Alcohol Drugs. 2009 Mar;70(2):186-96. PMID: 19261230. 47. … Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial.

239. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
     January 01, 2011 - PICO Population(s): Adult patients with PAD and comorbid or multimorbid disease Intervention(s): Drugs

240. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Curr Opin Investig Drugs. 2001 Apr;2(4):505-9. PMID: 11566007 30. Tappenden K, Edelman J. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec [accessed 2013 Jun 5]. [19 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Oct 16 [accessed 2012 Oct 16]. [3 p].